ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Hospital Universitario Virgen de la Victoria at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Hospital Universitario Virgen de la Victoria takes part in 4 sessions at ESMO 2026 in Madrid. Its work centres on breast and gynaecological cancers, with a focus on genomic markers and real-world treatment outcomes. It examines how gene-expression profiles relate to recurrence risk in hormone receptor-positive breast cancer and how BRCA mutation location relates to PARP inhibitor outcomes in ovarian cancer.
| Organization | ESMO 2026 Attendance |
|---|---|
HU Hospital Universitario Virgen de la Victoria Málaga, Spain | |
University hospital in Málaga, Spain. | Poster Fri Oct 23 13:00–15:00 Correlation between PGR, ESR1, and MKI67 gene expression determined by RT-qPCR and recurrence risk estimated by a multigene assay in HR+/HER2− breast cancer (SCORE study) Breast cancerBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Correlation of genomic profiles across germline, tumour and liquid samples in high grade epithelial ovarian cancer Gynaecological cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 RWD about efficacy of PARP inhibitors in HGOC according to BRCA mutation location Gynaecological cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Genomic characterization of Reed-Sternberg cells as a prognostic marker in classic Hodgkin lymphoma: GOTEL Haematological malignanciesBiomarkers & precision oncology Poster Sun Oct 25 12:00–12:45 |
Find decision makers at Hospital Universitario Virgen de la Victoria
Tell us what you sell and we’ll find the people at Hospital Universitario Virgen de la Victoria most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction